1,819 Shares in STERIS plc (NYSE:STE) Purchased by Crux Wealth Advisors

Crux Wealth Advisors purchased a new position in STERIS plc (NYSE:STE - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 1,819 shares of the medical equipment provider's stock, valued at approximately $374,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Avalon Trust Co purchased a new stake in shares of STERIS during the fourth quarter worth about $30,000. Human Investing LLC purchased a new position in shares of STERIS during the fourth quarter valued at about $31,000. Anfield Capital Management LLC raised its stake in STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after buying an additional 91 shares in the last quarter. Central Pacific Bank Trust Division lifted its holdings in STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after buying an additional 76 shares during the period. Finally, Manchester Capital Management LLC boosted its position in STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after acquiring an additional 137 shares in the last quarter. Institutional investors own 94.69% of the company's stock.

STERIS Stock Down 1.3 %

Shares of NYSE:STE traded down $2.85 on Tuesday, hitting $221.17. 342,204 shares of the company traded hands, compared to its average volume of 532,660. The stock has a 50 day simple moving average of $222.59 and a 200-day simple moving average of $219.41. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The company has a market cap of $21.73 billion, a PE ratio of 46.96 and a beta of 0.87. STERIS plc has a 52 week low of $197.82 and a 52 week high of $248.24.

Remove Ads

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, research analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were issued a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.03%. STERIS's payout ratio is currently 48.41%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on STE. Needham & Company LLC reissued a "hold" rating on shares of STERIS in a research report on Monday, April 7th. JMP Securities reiterated a "market outperform" rating and issued a $265.00 price objective on shares of STERIS in a report on Thursday, April 10th. Piper Sandler boosted their target price on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Finally, Stephens reiterated an "overweight" rating and issued a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.